Oxidative stress and reactive oxygen species

Contributions to Nephrology

Volumn 149, Issue , 2005, Pages 240-260

  Galli, Francesco ^a   Piroddi, Marta ^a   Annetti, Claudia ^a   Aisa, Cristina ^a   Floridi, Emanuela ^a   Floridi, Ardesio ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE;

ARTERIOSCLEROSIS; HUMAN; METABOLISM; NOMENCLATURE; OXIDATIVE STRESS; REVIEW; SYNDROME; UREMIA;

ARTERIOSCLEROSIS; HUMANS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SYNDROME; TERMINOLOGY; UREMIA;

EID: 20544453303     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000085686     Document Type: Article

References (62)

1. Halliwell B, Gutteridge J: Free Radicals in Biology and Medicine, ed 3 New York, Oxford University Press, 1999.
2. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM: The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-1538.
3. Galle J, Seibold S, Wanner C: Inflammation in uremic patients: What is the link? Kidney Blood Press Res 2003;26:65-75.
4. Shishehbor MH, Hazen SL: Inflammatory and oxidative markers in atherosclerosis: Relationship to outcome. Curr Atheroscler Rep 2004;6:243-250.
5. Kyaw M, Yoshizumi M, Tsuchiya K, Izawa Y, Kanematsu Y, Tamaki T: Atheroprotective effects of antioxidants through inhibition of mitogen-activated protein kinases. Acta Pharmacol Sin 2004;25:977-985.
6. Ceaser EK, Moellering DR, Shiva S, Ramachandran A, Landar A, Venkartraman A, Crawford J, Patel R, Dickinson DA, Ulasova E, Ji S, Darley-Usmar VM: Mechanisms of signal transduction mediated by oxidized lipids: The role of the electrophile-responsive proteome. Biochem Soc Trans 2004;32:151-155.
7. Davignon J, Ganz P: Role of endothelial dysfunction in atherosclerosis. Circulation 2004;109:III27-32.
8. Wautier JL, Schmidt AM: Protein glycation: A firm link to endothelial cell dysfunction. Circ Res 2004;95:233-238.
9. Francois M, Kojda G: Effect of hypercholesterolemia and of oxidative stress on the nitric oxide-cGMP pathway. Neurochem Int 2004;45:955-961.
10. Boullier A, Bird DA, Chang MK, Dennis EA, Friedman P, Gillotre-Taylor K, Horkko S, Palinski W, Quehenberger O, Shaw P, Steinberg D, Terpstra V, Witztum JL: Scavenger receptors, oxidized LDL, and atherosclerosis. Ann NY Acad Sci 2001;947:214-222; discussion 222-223.
11. Galli F, Canestrari F, Buoncristiani U: Biological effects of oxidant stress in haemodialysis: The possible roles of vitamin E. Blood Purif 1999;17:79-94.
12. Galli F, Ghibelli L, Buoncristiani U, Bordoni V, D'Intini V, Benedetti S, Canestrari F, Ronco C, Floridi A: Mononuclear leukocyte apoptosis in haemodialysis patients: The role of cell thiols and vitamin E. Nephrol Dial Transplant 2003;18:1592-1600.
13. 2-induced block of glycolysis as an active ADP-ribosylation reaction protecting cells from apoptosis. FASEB J 2000;14:2266-2276.
14. Gopalakrishna R, Jaken S: Protein kinase C signaling and oxidative stress. Free Radic Biol Med 2000;28:1349-1361.
15. Curtis TM, Scholfield CN: The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev 2004;20:28-43.
16. Chen K, Keaney J: Reactive oxygen species-mediated signal transduction in the endothelium. Endothelium 2004;11:109-121.
17. Zoccali C, Mallamaci F, Tripepi G: Novel cardiovascular risk factors in end-stage renal disease. J Am Soc Nephrol 2004;15(suppl 1):S77-S80.
18. Butterfield DA, Castegna A, Lauderback CM, Drake J: Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002;23:655-664.
19. Gackowski D, Kowalewski J, Siomek A, Olinski R: Oxidative DNA damage and antioxidant vitamin level: Comparison among lung cancer patients, healthy smokers and nonsmokers. Int J Cancer 2004.
20. Stocker R, Keaney JF Jr: Role of oxidative modifications in atherosclerosis. Physiol Rev 2004;84:1381-1478.
21. Napoli C, Palinski W: Neurodegenerative diseases: Insights into pathogenic mechanisms from atherosclerosis. Neurobiol Aging 2005;26:293-302.
22. Napoli C, Quehenberger O, De Nigris F, Abete P, Glass CK, Palinski W: Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J 2000;14:1996-2007.
23. Wratten ML, Tetta C, Ursini F, Sevanian A: Oxidant stress in hemodialysis: Prevention and treatment strategies. Kidney Int Suppl 2000;76:S126-S132.
24. 2-isoprostane biosynthesis and inhibition in man. Chem Phys Lipids 2004;128:149-163.
25. Jenkins AJ, Rowley KG, Lyons TJ, Best JD, Hill MA, Klein RL: Lipoproteins and diabetic microvascular complications. Curr Pharm Des 2004;10:3395-3418.
26. Quaschning T, Krane V, Metzger T, Wanner C: Abnormalities ill uremic lipoprotein metabolism and its impact on cardiovascular disease. Am J Kidney Dis 2001;38:S14-S19.
27. Matsuoka H: Endothelial dysfunction associated with oxidative stress in human. Diabetes Res Clin Pract 2001;54(suppl 2):S65-S72.
28. Torzewski M, Shaw PX, Han KR, Shortal B, Lackner KJ, Witztum JL, Palinski W, Tsimikas S: Reduced in vivo aortic uptake of radiolabeled oxidation-specific antibodies reflects changes in plaque composition consistent with plaque stabilization. Arterioscler Thromb Vase Biol 2004;24:2307-2312.
29. Nakamura T, Kawagoe Y, Matsuda T, Takahashi Y, Sekizuka K, Ebihara I, Koide H: Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans. Kidney Blood Press Res 2003;26:185-191.
30. Miyazaki H, Matsuoka H, Itabe H, Usui M, Ueda S, Okuda S, Imaizumi T: Hemodialysis impairs endothelial function via oxidative stress: Effects of vitamin E-coated dialyzer. Circulation 2000;101:1002-1006.
31. Palinski W, Napoli C: Unraveling pleiotropic effects of statins on plaque rupture. Arterioscler Thromb Vasc Biol 2002;22:1745-1750.
32. Steptoe A, Perkins-Porras L, Hilton S, Rink E, Cappuccio FP: Quality of life and self-rated health in relation to changes in fruit and vegetable intake and in plasma vitamins C and E in a randomised trial of behavioural and nutritional education counselling. Br J Nutr 2004;92:177-184.
33. Willcox JK, Ash SL, Catignani GL: Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 2004;44:275-295.
34. Boaz M, Smetana S, Weinstein T, Matas Z, Gaffer U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial. Lancet 2000;356:1213-1218.
35. Voko Z, Hollander M, Hofman A, Koudstaal PJ, Breteler MM: Dietary antioxidants and the risk of ischemic stroke: The Rotterdam Study. Neurology 2003;61:1273-1275.
36. Lipinski B: Markers of oxidative stress in uremia. Kidney Int 2004;65:339-340; author reply 340.
37. Tarng DC, Wen Chen T, Huang TP, Chen CL, Liu TY, Wei YH: Increased oxidative damage to peripheral blood leukocyte DNA in chronic peritoneal dialysis patients. J Am Soc Nephrol 2002;13:1321-1330.
38. Kalousova M, Zima T, Tesar Y Sulkova S, Fialova L: Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis patients. Kidney Int Suppl 2003;S62-S64.
39. Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Norpoth M, Giovannini L, Palla R, Tetta C: C-reactive protein as a marker of chronic inflammation in uremic patients. Blood Purif 2000;18:183-190.
40. Descamps-Latscha B, Witko-Sarsat V: Importance of oxidatively modified proteins in chronic renal failure. Kidney Int Suppl 2001;78:S108-S113.
41. 2-isoprostane levels are elevated in chronic hemodialysis patients. Clin Nephrol 2002;58:190-197.
42. Hörl WH: Hemodialysis membranes: Interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 2002;13(suppl 1):S62-S71.
43. D'Intini V, Bordoni V, Fortunato A, Galloni E, Carta M, Galli F, Bolgan I, Inguaggiato P, Poulin S, Bonello M, Tetta C, Levin N, Ronco C: Longitudinal study of apoptosis in chronic uremic patients. Semin Dial 2003;16:467-473.
44. Canestrari F, Galli F, Giorgini A, Albertini MC, Galiotta P, Pascucci M, Bossu M: Erythrocyte redox state in uremic anemia: Effects of hemodialysis and relevance of glutathione metabolism. Acta Haematol 1994;91:187-193.
45. Galli F, Canestrari F, Bellomo G: Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib Nephrol 1999;127:1-31.
46. Libetta C, Zucchi M, Gori E, Sepe V, Galli F, Meloni F, Milanesi F, Canton AD: Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int 2004;65:1473-1481.
47. Galli F: Special issue: Amino acid and protein modifications by oxygen and nitrogen species. Amino Acids 2003;25:205.
48. Galli F, Benedetti S, Floridi A, Canestrari F, Piroddi M, Buoncristiani E, Buoncristiani U: Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers. Kidney Int 2005;67:750-759.
49. Maccarrone M, Taccone-Gallucci M, Finazzi-Agro A: 5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients. Kidney Int Suppl 2003;S33-S36.
50. Rosensen RS: Statins in atherosclerosis: Lipid-lowering agents with antioxidant capabilities. Atherosclerosis 2004;173:1-12.
51. Bertrand ME: Provision of cardiovascular protection by ACE inhibitors: A review of recent trials. Curr Med Res Opin 2004;20:1559-1569.
52. Usberti M, Gerardi G, Bufano G, Tira P, Micheli A, Albertini A, Floridi A, Di Lorenzo D, Galli F: Effects of erythropoietin and vitamin E-modified membrane on plasma oxidative stress markers and anemia of hemodialyzed patients. Am J Kidney Dis 2002;40:590-599.
53. Grune T, Sommerburg O, Siems WG: Oxidative stress in anemia. Clin Nephrol 2000;53:S18-S22.
54. Sato M, Matsumoto Y, Morita H, Takemura H, Shimoi K, Amano I: Effects of vitamin supplementation on microcirculatory disturbance in hemodialysis patients without peripheral arterial disease. Clin Nephrol 2003;60:28-34.
55. Morena M, Cristol JP, Canaud B: Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif 2000;18:191-199.
56. Williamson KS, Gabbita SP, Mou S, West M, Pye QN, Markesbery WR, Cooney RV, Grammas P, Reimann-Philipp U, Floyd RA, Hensley K: The nitration product 5-nitro-gamma-tocopherol is increased in the Alzheimer brain. Nitric Oxide 2002;6:221-227.
57. Behl C: Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res 1999;69:213-219.
58. Fang YZ, Yang S, Wu G: Free radicals, antioxidants, and nutrition. Nutrition 2002;18:872-879.
59. Calabrese V, Scapagnini G, Colombrita C, Ravagna A, Pennisi G, Giuffrida Stella AM, Galli F, Butterfield DA: Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: A nutritional approach. Amino Acids 2003;25:437-444.
60. Zhang WR, Hayashi T, Sasaki C, Sato K, Nagano I, Manabe Y, Abe K: Attenuation of oxidative DNA damage with a novel antioxidant EPC-K1 in rat brain neuronal cells after transient middle cerebral artery occlusion. Neurol Res 2001;23:676-680.
61. Becker LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004;61:461-470.
62. Wainwright CL: Matrix metalloproteinases, oxidative stress and the acute response to acute myocardial ischaemia and reperfusion. Curr Opin Pharmacol 2004;4:132-138.